To regulate the RAGE, MR, and NFκB pathway, we orally treated our aneurysm model rats for 6 weeks with a mineral corticoid receptor blocker, ESA, at 1 mg/kg (Fig. 4A), based on previous studies [18, 20]. The gene discussed is NR3C2; the disease is aneurysm.